# ANDA Submissions — Content and Format of Abbreviated New Drug Applications:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/anda-submissions-content-and-format-of-abbreviated-new-drug-applications-guidance-for-industry/9e96159f-7071-4167-b6c2-79004f8ffc79

> FDA guidance document: ANDA Submissions — Content and Format of Abbreviated New Drug Applications:  Guidance for Industry. Issue date: June 20, 2019. Get complete insights and analysis.

---

## Details

- Title: ANDA Submissions — Content and Format of Abbreviated New Drug Applications:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-06-20
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0725">FDA-2014-D-0725</a>

## Related Documents

- [Referencing Approved Drug Products in ANDA Submissions Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/referencing-approved-drug-products-in-anda-submissions-guidance-for-industry/a3f26b8f-0c5a-443b-b665-6fef99ae7de4)
- [E8(R1) General Considerations for Clinical Studies](https://www.globalkeysolutions.net/guidances/guidance-document/e8r1-general-considerations-for-clinical-studies/c5e52286-b058-4b0f-b1f2-e589be1aaf84)
- [Format and Content of a REMS Document Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-a-rems-document-guidance-for-industry/7d3af53b-d82d-41fe-9a2f-31d366c94701)